Dr. Andy Kilianski is the Chief Intelligence Officer for the DoD’s Joint Program Executive Office for CBRN Defense. As the J2 for JPEO-CBRND, his work focuses on combating weapons of mass destruction and infectious diseases, counterintelligence threats to the DoD’s Chemical and Biological Defense Program, and emerging threat characterization and assessment. He is also a visiting professor in the Schar School of Government at George Mason University.

Dr. Kilianski was previously the CBRN Defense Team Lead at the Defense Intelligence Agency – National Center for Medical Intelligence where he led a team of analysts covering worldwide WMD and medical science and technology developments. While at DIA, he was awarded the National Intelligence Professional Award and the National Counterterrorism Award from the Director of National Intelligence for leading USG-efforts to combat WMD proliferation. He also earned a certification in Defense All-Source Analysis from the Undersecretary of Defense for Intelligence.

Prior to entering public service, Dr. Kilianski was a National Academy of Sciences Fellow with the U.S. Army at Edgewood Chemical Biological Center. His tenure at ECBC involved leading research and program development for integrated biosurveillance and the identification and characterization of novel agents that threaten today’s warfighter. His research has been published in peer-reviewed journals such as PLoS Pathogens, Journal of Virology, and Emerging Infectious Diseases while also publishing multiple commentaries on emerging threat science policy.

He received his Ph.D. in Microbiology and Immunology from Loyola University Chicago where he discovered virus-host interactions necessary for coronavirus pathogenesis. His worked included vaccine and antiviral development against the emerging human viruses Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS) coronaviruses.